Nonetheless, more studies considering the genetic variability in GSTs with increased sample sizes in different ethnicities are needed to decipher new susceptibility and prognostic markers in ALL to optimize personalized therapeutic approach. Here, HPGDS is linked to acute lymphoblastic leukemia.